Since 2014, Wenatone leads in hearing tech with unique algorithms for clarity. Specializing in noise reduction, our aids adapt to any setting. Merging tech with modern living—OTC products integrate with apps, syncing devices, and providing top-quality music and calls. Join us in shaping auditory wellness & succeed together.
Xiamen Emoka Health Science & Technology Co.,Ltd.
Founded in 2008, Xiamen Emoka excels in high-end massager OEM/ODM, with 17 years’ expertise, serving 500+ global top brands and 3,438+ SKUs. A drafter of China’s industry standards, we pioneered stepless adjustable neck massagers. Our 28+ years core design team offering full customization.Partner with us for exclusive solutions!
Xenra
Your Wi-Fi already connects. Now it senses. Xenra transforms ambient Wi-Fi into real-time wellness, sleep, and presence insights – no cameras, wearables, or cloud. Our plug-and-play device works through bedding, clothing, and everyday barriers, with privacy-first views on your local dashboard. Demo at Booth EP-61037!
XELA Robotics
XELA Robotics, based in Tokyo and with customers worldwide, is a specialist in advanced 3D tactile sensors. Its sensors, both standalone and integrated into grippers and robot hands, unlock real automation. The company’s solutions, including hardware and software, are durable, compact, easy to integrate and highly cost-effective. | Originated as a spin-out from Waseda University, one of the top universities in Tokyo, XELA Robotics has a strong academic background. Furthermore, XELA Robotics is at the forefront of developing advanced tactile Al technologies. Additionally, we have dedicated personnel for business activities, ensuring a well-rounded approach to meet our clients’ needs. It is our mission to optimise industries with our uSkin technology a high-density, 3-axis tactile sensor that provides robots with a human-like sense of touch. uSkin significantly enhances robots’ precision in handling tasks across assembly, packaging, agriculture, and more. As we face the challenge of a rapidly aging population, our mission is to boost productivity by integrating uSkin into robots, making them efficient assistants in daily human activities. Through innovation and technology, XELA Robotics is bridging the gap towards a future where robots can seamlessly support our workforce, ensuring a more productive and sustainable economy.
Xcube Co., Ltd.
XCUBE develops CT automation software powered by patented multi-organ segmentation and voxel-based 3D anatomical modeling technology. With global patents and clinical validation, our platform enables diagnostic automation, surgical planning, and expanded screening services without additional hardware or workflow modifications. Turning com
Xcell Therapeutics Inc.
Company Overview: Xcell Therapeutics Inc. Leading the Global Standard in Chemically Defined Media for Regenerative Medicine Xcell Therapeutics (KOSDAQ: 373110) is a pioneering biotechnology company dedicated to providing the foundational technology for the next generation of Cell and Gene Therapies (CGT). We specialize in the development and mass production of high-performance, Chemically Defined (CD) media, offering a safer and more efficient alternative to traditional animal-derived or human-blood-based culture environments. As the first company in the world to commercialize CD media for Mesenchymal Stem Cells (MSCs), our flagship brand CellCor™ is engineered to meet the rigorous demands of the global biopharmaceutical industry. By utilizing only high-purity synthetic components and recombinant proteins, CellCor™ eliminates the inherent risks of viral contamination and batch-to-batch inconsistency associated with serum-based media. This ensures predictable, high-quality cell expansion, which is critical for successful clinical outcomes and large-scale cGMP manufacturing. Building on our core expertise in MSCs, Xcell Therapeutics is actively expanding its influence in the immune cell therapy market. We are proudly promoting our advanced media solutions specifically optimized for Immune Cells, such as T-cells and NK-cells, as well as Exosome recovery. Our technology is designed to accelerate the transition from bench to bedside, providing regulatory-friendly solutions that streamline the path to commercialization for our global partners. Xcell Therapeutics is not just a supplier, but a strategic partner in bioprocessing innovation. We invite you to explore how our CD media solutions can optimize your workflows and define the future of advanced medicine.
xBiologix
xBiologix designs, builds, customizes & validates biomarker profiling products & protocols for solid tissue imaging using our patent pending, click-chemistry reagents & conventional multiplexed immunofluorescent platforms. Our multispectral imaging, antibody-oligo products characterize tumor microenvironments & surrounding tissue with a single incubation of (4-20) primary antibodies & gentle signal removal/re-imaging protocol. This simplified, “one pot” staining protocol is uniquely suited to conventional autostaining & multispectral imaging platforms, & amenable to workflow standardization & validation supporting research & clinical laboratory processes. | xBiologix provides multiplexed, fluorescent microscopy products and service supporting our spatial biology customers. Our ready-to-use, platform independent, pre-validated, massively multiplexed immunofluorescent IHCs (mIHC/IF) protocol radically simplifying the published cyclic protocols— a.k.a cycIF. We seek to partner with small oncology focused drug developers who want to reliably identify potential trial participants by screening patient resected tumors for the candidate’s mode of action.
XBM USA LLC
Founded in 2020 and over the past 5 years, Xponential Battery Materials (XBM USA) has been working to develop CarbonX™, a superior, sustainable lithium-sulfur (Li-S) Cathode Active Material (CAM). The company is working with US OEMs developing next-generation high-performance and low-weight eAreospace and EV battery applications. CarbonX pairs step-change performance with a fully domestic, low-risk supply chain, offering ~2× the cathode capacity vs today’s NMC or LFP cathodes at ~40–50% lower $/kWh, using abundant U.S. industrial byproducts, (sulfur from petroleum refining and tannin/lignin from paper and pulping), as core base materials that helps mitigate polysulfide shuttle, enabling stable high-capacity operation and longer cycle life. The result is a circular-economy CAM manufactured entirely in the United States and sourced across the Americas. CarbonX’s ~40% cathode savings can translate to up to ~25% reduction in total battery cell cost. XBM expects initial commercial deployments in eAreospace, EV and consumer battery markets.
Xandar Kardian Inc.
Xandar Kardian uses FDA-cleared radar technology to monitor vital signs continuously without touching patients. We work across hospitals, nursing facilities, and homes. Our AI advancements are making alerts more accurate and actionable, helping care teams respond faster.